全球數位療法市場規模、佔有率、趨勢和成長分析報告（2026-2034）

數位療法市場預計將從 2025 年的 106 億美元成長到 2034 年的 996.7 億美元，2026 年至 2034 年的複合年成長率為 28.28%。

隨著醫療服務提供者採用技術主導的治療方案，全球數位療法市場正在快速成長。數位療法利用軟體為基礎的程序，透過實證干預措施來治療、管理或預防疾病。這些解決方案通常透過行動應用程式、穿戴式裝置和線上平台提供。

多種因素正在推動數位療法市場的成長。慢性病盛行率的上升和數位醫療技術的廣泛應用，促進了基於軟體的治療工具的開發。醫療服務提供者也在探索數位療法，將其作為一種經濟有效的解決方案，以提高患者的參與度和治療依從性。

隨著醫療保健系統擁抱數位轉型，數位療法市場預計將會擴張。人工智慧、數據分析和遠端監測技術的進步有望改善治療效果。隨著患者和醫療服務提供者擴大採用數位健康工具，數位療法將成為現代醫學的關鍵組成部分。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球數位治療藥物市場：按應用領域分類

• 市場分析、洞察與預測
• 糖尿病
• 肥胖
• CVD
• 呼吸系統疾病
• 禁止抽煙
• 中樞神經系統疾病
• 其他

第5章：全球數位治療藥物市場：依最終用途分類

• 市場分析、洞察與預測
• 病人
• 提供者
• 付款人
• 雇主
• 其他

第6章 全球數位治療藥物市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第7章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第8章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Omada Health Inc
  • Welldoc Inc
  • 2Morrow Inc
  • Livongo Health Inc.（Teladoc Health Inc.）
  • Propeller Health（ResMed）
  • Fitbit LLC
  • Mango Health
  • Canary Health
  • Noom Inc
  • Pear Therapeutics Inc
  • Akili Interactive Labs Inc
  • Hygieia
  • DarioHealth Corp
  • BigHealth
  • GAIA AG
  • Limbix Health Inc

The Digital Therapeutics Market size is expected to reach USD 99.67 Billion in 2034 from USD 10.60 Billion (2025) growing at a CAGR of 28.28% during 2026-2034.

The global digital therapeutics market has grown rapidly as healthcare providers adopt technology-driven treatment solutions. Digital therapeutics use software-based programs to treat, manage, or prevent medical conditions through evidence-based interventions. These solutions are commonly delivered through mobile applications, wearable devices, and online platforms.

Several drivers are supporting the growth of the digital therapeutics market. Increasing prevalence of chronic diseases and growing adoption of digital health technologies have encouraged the development of software-based treatment tools. Healthcare providers are also exploring digital therapeutics as cost-effective solutions that improve patient engagement and treatment adherence.

Looking ahead, the digital therapeutics market is expected to expand as healthcare systems embrace digital transformation. Advances in artificial intelligence, data analytics, and remote monitoring technologies may enhance treatment effectiveness. As patients and providers increasingly adopt digital health tools, digital therapeutics will likely become an important component of modern healthcare.

MARKET SEGMENTATION

By Application

• Diabetes
• Obesity
• CVD
• Respiratory Diseases
• Smoking Cessation
• CNS Diseases
• Others

By End Use

• Patients
• Providers
• Payers
• Employers
• Others

COMPANIES PROFILED

• Omada Health Inc, Welldoc Inc, 2Morrow Inc, Livongo Health Inc Teladoc Health Inc, Propeller Health ResMed, Fitbit LLC, Mango Health, Canary Health, Noom Inc, Pear Therapeutics Inc, Akili Interactive Labs Inc, Hygieia, DarioHealth Corp, BigHealth, GAIA AG, Limbix Health Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL DIGITAL THERAPEUTICS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Application
• 4.2. Diabetes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Obesity Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. CVD Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Respiratory Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Smoking Cessation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. CNS Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL DIGITAL THERAPEUTICS MARKET: BY END USE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End Use
• 5.2. Patients Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Providers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Payers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Employers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL DIGITAL THERAPEUTICS MARKET: BY REGION 2022-2034 (USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Application
  • 6.2.2 By End Use
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Application
  • 6.3.2 By End Use
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Application
  • 6.4.2 By End Use
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Application
  • 6.5.2 By End Use
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Application
  • 6.6.2 By End Use
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL DIGITAL THERAPEUTICS INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Omada Health Inc
  • 8.2.2 Welldoc Inc
  • 8.2.3 2Morrow Inc
  • 8.2.4 Livongo Health Inc. (Teladoc Health Inc.)
  • 8.2.5 Propeller Health (ResMed)
  • 8.2.6 Fitbit LLC
  • 8.2.7 Mango Health
  • 8.2.8 Canary Health
  • 8.2.9 Noom Inc
  • 8.2.10 Pear Therapeutics Inc
  • 8.2.11 Akili Interactive Labs Inc
  • 8.2.12 Hygieia
  • 8.2.13 DarioHealth Corp
  • 8.2.14 BigHealth
  • 8.2.15 GAIA AG
  • 8.2.16 Limbix Health Inc